Neonatal aspergillosis (Q45768): Difference between revisions

← Older edit

@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/1791817517
@@ Property / Canonical URI: https://id.who.int/icd/entity/1791817517 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:KA63.1
@@ Property / CURIE: CID11:KA63.1 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-KA63.1
@@ Property / Canary Token: dki-india-KA63.1 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+P35-P39
@@ Property / Linked ICD 10: P35-P39 / rank @@
+Normal rank

Latest revision as of 13:57, 13 August 2026

A disease affecting neonates, caused by an infection with the fungi Aspergillus. This disease presents with clinical symptoms depending on the site of infection. Transmission is by inhalation of Aspergillus spores, or direct contact. Confirmation is by identification of Aspergillus from affected sites.

Language	Label	Description	Also known as
default for all languages	KA63.1
English	Neonatal aspergillosis	A disease affecting neonates, caused by an infection with the fungi Aspergillus. This disease presents with clinical symptoms depending on the site of infection. Transmission is by inhalation of Aspergillus spores, or direct contact. Confirmation is by identification of Aspergillus from affected sites.